David Pope

Chief Pharmacy Officer at Xifin. Redeemed. Family. Public Health. Pharmacists as Providers. Advocacy. Views are my own.

[Future of Pharmacy Care Coalition @FPCCoalition]

Must-read! Over 50% of Americans visited a pharmacy for a healthcare service in 2023, and this number “continues to rise,” writes David Pope, Chief Pharmacy Officer of @XiFin Solutions. Read David’s column here that urges Congress to pass #HR1770 #S2477: https://t.co/K4yIr0bXgp

[XiFin Pharmacy Solutions @OmniSYSNews]

Pharmacists-in-training must be informed of the changes in #pharmacycare. For #PharmacyStudentDay, we share beneficial insight on the move to value-based care: https://t.co/oPccmTuUtM

#APhM2023

[XiFin Pharmacy Solutions @OmniSYSNews]

As #healthcaredeserts grow, costs rise, and patient needs evolve, a partnership between #pharmacies and labs is a game-changer. Read the recent @Pharmacy_Times article to learn more. @DavidDPope

https://t.co/h3pu4gUakU

[David Pope @DavidDPope]

@lanceboles Solid group right there!

[XiFin Pharmacy Solutions @OmniSYSNews]

The power of collaboration. 🤝 On our #blog, @OmniSYSNews Chief Pharmacy Officer, @DavidDPope, delves into the potential of #laboratories and #pharmacies working hand in hand to innovate and elevate patient outcomes. Read it now: https://t.co/F02utL6OVI

[David Pope @DavidDPope]

Incredibly excited to work alongside @KyuRheeMD to advance the #pharmacy services to improve #healthequity

[XiFin Pharmacy Solutions @OmniSYSNews]

We're elated to announce that Dr. Kyu Rhee, former CVS Health physician executive, has joined @XiFin as a senior strategic advisor. His expertise will address #hospital and #pharmacy lab innovation in the age of big data and primary care transformation. https://t.co/gcpXUg7bGN

[XiFin Pharmacy Solutions @OmniSYSNews]

#ICYMI: New legislation has been introduced that would give tens of millions of #Medicare beneficiaries in underserved areas greater access to care. This is good news for #pharmacies and patients alike! Read about it here: https://t.co/mwQqyh8Kf2

[Chuck Grassley @ChuckGrassley]

Our nation’s seniors should hv access to their local pharmacists 4 wellness screenings, diabetes mgmt & more Introd bipartisan Pharmacy & Medically Underserved Areas Enhancement Act to improve access in rural/underserved areas

[XiFin Pharmacy Solutions @OmniSYSNews]

📣 @DrugStoreNews' #REXAwards2023 winners have been announced! @OmniSYSNews has been recognized for outstanding technology and automation innovation in #pharmacy solutions. Read all about it here: https://t.co/dRdX7VUnWU

[David Pope @DavidDPope]

@OmniSYSNews Excited to connect at EWC!

[XiFin Pharmacy Solutions @OmniSYSNews]

The conversation around Test-to-Treat continues to heat up. 🔥Join our expert roundtable #webinar today and get the scoop on billing nuances, workflows, and vital partnerships to operationalize #testtotreat today!

REGISTER: https://t.co/2zVBs0rZ8z

#pharmacy #clinicalpharmacy

[David Pope @DavidDPope]

@TerryForsheeRx Oh my. Praying for you and your family Terry.

[XiFin Pharmacy Solutions @OmniSYSNews]

The @Drug_Topics editorial board, including OmniSYS's @DavidDPope, got together this week to respond to the AMA's criticism of the #pharmacy test to treat initiative.

Read the full response here: https://t.co/G9BLDnsfFX

[David Pope @DavidDPope]

Well done pharmacy groups! We’re getting closer to #testandtreat. Widespread coordination of pharmacy groups on this subject.

[NCPA @Commpharmacy]

@Commpharmacy and 13 pharmacy groups urge POTUS to expand #TestandTreat. https://t.co/5Bvhu6rUrE

[NCPA @Commpharmacy]

@Commpharmacy and 13 pharmacy groups urge POTUS to expand #TestandTreat. https://t.co/5Bvhu6rUrE

[Pharmacy Times @Pharmacy_Times]

Despite early excitement, the Biden Administration's test-to-treat plan does not drastically alter pharmacists' roles according to experts @DavidDPope and @DrMadisonrx.

Learn more: https://t.co/LBcfL5n7ya

[XiFin Pharmacy Solutions @OmniSYSNews]

@DavidDPope and @PublicHealthRx sat down with @Pharmacy_Times to discuss the pharmacy #COVID19 test to treat initiative. Bottom line? #TesttoTreat does not alter pharmacists roles. But it should. And David and Christina talk about why.

https://t.co/dvnWmcNnHH

[XiFin Pharmacy Solutions @OmniSYSNews]

The conversation around pharmacist #COVID19 test to treat from the #STOU is heating up. Bottom line? #Pharmacists are qualified to make basic medical necessity determinations, and they are already doing it today in a number of instances. Read more below from @DavidDPope.

[David Pope @DavidDPope]

@SteveMooreRx @IDPharmProf Same

[David Pope @DavidDPope]

@IDPharmProf @blandman19 Reimbursing pharmacists for the Evaluation and Management (e.g. office visit) of prescribing would solve for this.